SEELOS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Seelos Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Seelos Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 3.32M shares, a 97.3% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.32M -121M -97.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 15.3M -107M -87.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.22M -2.35M -65.7% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 160M +52.3M +48.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 124M +18M +16.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 122M +16.2M +15.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.57M -102M -96.6% Dec 31, 2022 10-K 2024-03-06
Q3 2022 107M +4.81M +4.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 106M +3.92M +3.83% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 106M +27.3M +34.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 106M +51M +93.5% Dec 31, 2021 10-K 2023-03-10
Q3 2021 102M +49.1M +92.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 102M +57.9M +130% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 78.3M +34.3M +77.9% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 54.5M +27.5M +102% Dec 31, 2020 10-K 2022-03-04
Q3 2020 53.3M +26.3M +97.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 44.4M +23.1M +109% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 44M +23.8M +118% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 27M +23.9M +777% Dec 31, 2019 10-K 2021-03-11
Q3 2019 26.9M -1.19M -4.22% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 21.3M -2.16M -9.23% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 20.2M +3.87M +23.7% Mar 31, 2019 10-Q 2019-05-21
Q4 2018 3.08M +2.57M +508% Dec 31, 2018 10-K 2020-03-17
Q3 2018 28.1M +13.1M +87.2% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 23.4M +10.7M +83.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 16.3M +8.6M +111% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 507K -7.23M -93.4% Dec 31, 2017 10-K 2019-03-28
Q3 2017 15M +7.3M +94.3% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 12.8M -49.1M -79.3% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 7.74M -54M -87.5% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 7.73M +2.69M +53.4% Dec 31, 2016 10-K 2018-03-01
Q3 2016 7.73M -42.7M -84.7% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 61.9M +11.5M +22.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 61.8M +11.4M +22.5% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 5.04M -39.3M -88.6% Dec 31, 2015 10-K 2017-03-13
Q3 2015 50.4M +10.4M +26% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 50.4M +12.3M +32.3% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 50.4M +12.6M +33.2% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 44.3M +6.79M +18.1% Dec 31, 2014 10-K 2016-03-09
Q3 2014 40M +2.49M +6.64% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 38.1M +1.12M +3.03% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 37.9M +7.5M +24.7% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 37.5M +7.6M +25.4% Dec 31, 2013 10-K 2015-03-16
Q3 2013 37.5M +7.93M +26.8% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 37M +9.99M +37% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 30.4M +3.74M +14.1% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 29.9M +8.59M +40.2% Dec 31, 2012 10-K 2014-03-17
Q3 2012 29.6M +8.94M +43.3% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 27M +6.98M +34.9% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 26.6M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 21.3M +2.83M +15.3% Dec 31, 2011 10-K 2013-03-18
Q3 2011 20.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 20M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 18.5M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.